Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AND017 in Anemia of NDD-CKD
NCT05035641Phase 2Completed
- Sponsor
- Kind Pharmaceuticals LLC
- Start
- Oct 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of AND017 in anemia of chronic kidney disease (CKD-A), sponsored by Kind Pharmaceuticals LLC. Started Oct 2021; status: completed.
02
Drugs
AND017
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT05035641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05035641.